The goal of this study is to identify the mechanisms activated by Oct4 and Sox2 reprogramming transcription factors that drive glioma-propagating stem cells and determine their potential as targets for developing novel anti-cancer therapeutics. Here, POU5F1 is linked to central nervous system cancer.